Mouse Anti-HOXD3 (AA 334-431) Recombinant Antibody (CBFYH-1843) (CBMAB-H0655-FY)

Cui, Y., Chao, L. V., Wen, Y., Zhao, D., Yang, Y., Qiu, H., & Wang, C. (2022). HOXD3 up-regulating KDM5C promotes malignant progression of diffuse large B-cell lymphoma by decreasing p53 expression. Balkan Medical Journal, 39(1), 30.

Wang, L., Gao, Y., Tong, D., Wang, X., Guo, C., Guo, B., ... & Huang, C. (2021). MeCP2 drives hepatocellular carcinoma progression via enforcing HOXD3 promoter methylation and expression through the HB‐EGF/EGFR pathway. Molecular Oncology, 15(11), 3147-3163.

Lin, S., Zhuang, J., Zhu, L., & Jiang, Z. (2020). Matrine inhibits cell growth, migration, invasion and promotes autophagy in hepatocellular carcinoma by regulation of circ_0027345/miR-345-5p/HOXD3 axis. Cancer cell international, 20, 1-12.

Wang, L., Gao, Y., Zhao, X., Guo, C., Wang, X., Yang, Y., ... & Wang, W. (2020). HOXD3 was negatively regulated by YY1 recruiting HDAC1 to suppress progression of hepatocellular carcinoma cells via ITGA2 pathway. Cell Proliferation, 53(8), e12835.

Zhu, Y., Liu, Y., Xiao, B., Cai, H., Liu, M., Ma, L., ... & Wang, F. (2019). The circular RNA PVT1/miR-203/HOXD3 pathway promotes the progression of human hepatocellular carcinoma. Biology open, 8(9), bio043687.

Yang, M. H., Zhao, L., Wang, L., Ou-Yang, W., Hu, S. S., Li, W. L., ... & Wang, S. (2019). Nuclear lncRNA HOXD-AS1 suppresses colorectal carcinoma growth and metastasis via inhibiting HOXD3-induced integrin β3 transcriptional activating and MAPK/AKT signalling. Molecular cancer, 18(1), 1-16.

Wang, J., Zhao, H., Dong, H., Zhu, L., Wang, S., Wang, P., ... & Tan, J. (2019). LAT, HOXD3 and NFE2L3 identified as novel DNA methylation-driven genes and prognostic markers in human clear cell renal cell carcinoma by integrative bioinformatics approaches. Journal of Cancer, 10(26), 6726.

Chang, S. E., Gao, Z., Yang, Y., He, K., Wang, X., Wang, L., ... & Huang, C. (2019). miR-99b-3p is induced by vitamin D3 and contributes to its antiproliferative effects in gastric cancer cells by targeting HoxD3. Biological Chemistry, 400(8), 1079-1086.

Wang, L., Tong, D., Guo, Q., Wang, X., Wu, F., Li, Q., ... & Huang, C. (2018). HOXD3 targeted by miR-203a suppresses cell metastasis and angiogenesis through VEGFR in human hepatocellular carcinoma cells. Scientific reports, 8(1), 2431.

Zhang, Y., Zhang, Q., Cao, Z., Huang, Y., Cheng, S., & Pang, D. (2018). HOXD3 plays a critical role in breast cancer stemness and drug resistance. Cellular Physiology and Biochemistry, 46(4), 1737-1747.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols